Paul Rennert
33Patents
15h-index
26Co-inventors
81Inventor score
Filing activity: Jun 3, 1994 → Feb 14, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6352694B1 | Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells | Chemistry; Metallurgy | 442 | Expired |
| US6534055B1 | Methods for selectively stimulating proliferation of T cells | Chemistry; Metallurgy | 388 | Expired |
| US6905680B2 | Methods of treating HIV infected subjects | Chemistry; Metallurgy | 323 | Expired |
| US6887466B2 | Methods for selectively stimulating proliferation of T cells | Chemistry; Metallurgy | 322 | Expired |
| US6905681B1 | Methods for selectively stimulating proliferation of T cells | Chemistry; Metallurgy | 320 | Expired |
| US5858358A | Methods for selectively stimulating proliferation of T cells | Chemistry; Metallurgy | 299 | Expired |
| US7175843B2 | Methods for selectively stimulating proliferation of T cells | Chemistry; Metallurgy | 286 | Expired |
| US7232566B2 | Methods for treating HIV infected subjects | Chemistry; Metallurgy | 277 | Expired |
| US7144575B2 | Methods for selectively stimulating proliferation of T cells | Chemistry; Metallurgy | 274 | Expired |
| US6444792B1 | CTLA4-C&ggr;4 fusion proteins | Chemistry; Metallurgy | 104 | Expired |
| US6719972B1 | Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies | Chemistry; Metallurgy | 62 | Expired |
| US6750334B1 | CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor | Chemistry; Metallurgy | 46 | Expired |
| US6875846B2 | Heterologous polypeptide of the TNF family | Human Necessities | 42 | Expired |
| US7479269B2 | Methods for selectively enriching TH1 and TH2 cells | Chemistry; Metallurgy | 21 | Active |
| US7169387B2 | Antagonists of tweak and of tweak receptor and their use to treat immunological disorders | Chemistry; Metallurgy | 19 | Expired |
| US7276241B2 | Methods of treating a tumor that expresses APRIL by administering BCMA | Chemistry; Metallurgy | 15 | Expired |
| US7255854B1 | Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7579001B2 | Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders | Chemistry; Metallurgy | 9 | Active |
| US7309492B2 | Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus | Emerging Cross-Sectional Technologies | 7 | Expired |
| US10508143B1 | Compositions and methods for treatment of cancer | Chemistry; Metallurgy | 4 | Active |
| US8440189B2 | Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders | Chemistry; Metallurgy | 3 | Active |
| US10066023B2 | Compositions and methods for tumor transduction | Chemistry; Metallurgy | 3 | Active |
| US7592007B2 | Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies | Chemistry; Metallurgy | 2 | Expired |
| US10072094B2 | Compositions and methods for tumor transduction | Chemistry; Metallurgy | 2 | Active |
| US10669349B2 | Compositions and methods for treatment of cancer | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.